Regulatory aspects of the vasoactive intestinal peptide receptor in lung.
Paul
S
S
Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City.
Chou
J
J
Said
S I
SI
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000032:analysis; D002793:Cholic Acids; D000242:Cyclic AMP / Q000096:biosynthesis; D004789:Enzyme Activation; D019204:GTP-Binding Proteins / Q000378:metabolism; D013007:Growth Hormone-Releasing Hormone / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006168:Guinea Pigs; D008168:Lung / Q000032:analysis*; D010741:Phospholipases A / Q000494:pharmacology; D011964:Receptors, Gastrointestinal Hormone / Q000302:isolation & purification / Q000502:physiology*; D018005:Receptors, Vasoactive Intestinal Peptide; D012995:Solubility; D010738:Type C Phospholipases / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D002793:Cholic Acids; D011964:Receptors, Gastrointestinal Hormone; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide; D006160:Guanosine Triphosphate; D013007:Growth Hormone-Releasing Hormone; D000242:Cyclic AMP; D010741:Phospholipases A; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; C028213:3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate